Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001021871 | SCV001183540 | pathogenic | Hereditary cancer-predisposing syndrome | 2019-08-12 | criteria provided, single submitter | clinical testing | The c.41_42dupGC pathogenic mutation, located in coding exon 1 of the MEN1 gene, results from a duplication of GC at nucleotide position 41, causing a translational frameshift with a predicted alternate stop codon (p.S15Afs*105). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |